Leukoplakia
📧 Sign up to get email alerts when something new happens for Leukoplakia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Artificial Intelligence Based Program to Classify Oral Cavity Findings Based on Clinical Image Analysis
This completed clinical trial evaluated an artificial intelligence program designed to classify oral cavity findings from clinical images. T…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions [Phase 1]
Phase 1 study evaluating metformin for prevention of oral cancer in patients with oral premalignant lesions has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-06-19Clinical Trial Update: Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial [Phase 2]
Phase 2 clinical trial update for photodynamic therapy using Metil 5-aminolevulinate targeting actinic cheilitis and leukoplakia.
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: Natural History of Oro-pharyngeal Cancer Precursors
A completed clinical trial investigating the natural history of precancerous conditions of the oropharynx, including leukoplakia, oral eryth…
-
CLINICAL_TRIALS trial_result · 2012-11-13Clinical Trial Update: Treatment of Oral Premalignant Lesions With 5-ALA PDT [Phase 1, Phase 2]
The document reports the completion of a Phase 1/2 clinical trial evaluating 5-ALA photodynamic therapy for oral premalignant lesions. The c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR [Phase 2]
A randomized, double-blind Phase IIb trial evaluated whether ketorolac mouth rinse, by inhibiting cyclooxygenase, affects oropharyngeal leuk…